Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Xarelto Promotion Resulted in $28.4M in Payments for Doctors in 2015: Report December 16, 2016 Irvin Jackson Add Your Comments In an effort to promote Xarelto and increase sales, a new report indicates the maker of the controversial anticoagulant doled out $28.4 million for U.S. doctors last year, in the form of speaking fees, dinners and gifts. The independent, public-interest news organization ProPublica released new data for its Dollars for Docs database earlier this week, highlighting the top five drugs associated with payments to doctors in 2015. The investigation found that companies pay about $2 billion in general payments for more than 600,000 physicians each year, and 2015 was no different. Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Xarelto Lawsuits Side Effects of Xarelto May Increase Risk of Uncontrollable Bleeding. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to the data, Xarelto topped the list of drugs associated with promotional payments to doctors. It was followed by $24.9 million in payments stemming from the promotion of Humira, $20.9 million linked to the diabetes drug Invokana, $19.2 million given to doctors to promote the hepatitis C drug Viekira, and $18.8 million in payments to promote Xarelto’s competing blood thinner, Eliquis. ProPublica’s findings highlight the potential conflicts of interests these payments create, as doctors on the dole are more likely to prescribe those drugs to their patients. “Combining previous payment data with prescribing data from the federal Medicare program, we’ve shown that physicians who receive payments from the industry tend to prescribe more brand-name drugs than those who don’t,” ProPublica investigators wrote. “Several academic studies later had similar findings.” Xarelto Litigation Concerns over the promotional payments come as thousands of Xarelto lawsuits are moving forward against the drug makers, alleging that the anticoagulant was recklessly promoted without adequate warnings about the risk of severe and fatal bleeding. Xarelto (rivaroxaban) is part of a new class of blood thinners introduced in recent years as a replacement for warfarin, which had been the go-to anticoagulation treatment for decades. Since it was approved in 2011, this new-generation treatment has been commonly prescribed instead of warfarin for reduction of the risk of blood clots and strokes among patients with atrial fibrillation, or following hip or knee replacement surgery. Amid allegations that the drug makers failed to adequately warn about the risk of bleeding associated with the new-generation drug, more than 11,000 Xarelto lawsuits have been filed in courts throughout the U.S. Each of the complaints raise similar allegations, indicating that Xarelto caused uncontrollable bleeding problems, resulting in serious injury or wrongful death. While there is a known reversal agent that can stop the blood thinning effects of warfarin, there were no similar antidotes available for Xarelto at the time it was introduced, placing doctors in a position where they were unable to control many bleeding problems. Lawsuits also allege that the drug makers provided false and misleading information about the importance of blood monitoring on Xarelto, marketing the drug as easier to use and indicating that it does not require close testing like warfarin. However, independent studies published after the medication was introduced have suggested that Xarelto monitoring may help identify patients at greater risk of bleeds. As part of the coordinated proceedings in the federal Xarelto litigation, a small group of “bellwether” cases are being prepared for early trial dates, which are expected to begin early next year to help gauge how juries may respond to certain evidence that has been obtained during the discovery process. While the outcome of these early bellwether trials will not be binding in other cases, they may facilitate Xarelto settlement negotiations that will avoid the need for thousands of individual cases to go to trial nationwide. Tags: Bayer, Bleeding, Blood Thinner, Eliquis, Humira, Invokana, Johnson & Johnson, Viekira, Xarelto More Xarelto Lawsuit Stories Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024 Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022 Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (Posted: today) Following 52 years as a cosmetologist, a New Jersey woman says she developed bladder cancer due to routine exposure to hair color chemicals. MORE ABOUT: HAIR DYE LAWSUITHair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)Hairdresser Bladder Cancer Lawsuits Target L’Oréal, Henkel, Wella, Clairol and Other Popular Salon Dye Manufacturers (04/04/2025)Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (03/28/2025) Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: yesterday) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025) 500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: yesterday) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)
Andexxa Blood Clot Risks Lead to FDA Questions Regarding Safety of the Reversal Agent for Xarelto, Eliquis November 21, 2024
Xarelto Side Effects More Likely to Result in Death than Warfarin for Afib Patients with Heart Disease: Study September 1, 2022
Side Effects of Blood Thinners, Diabetes Drugs Are Leading Causes of ER Visits Due to Medications: Study October 15, 2021
Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (Posted: today) Following 52 years as a cosmetologist, a New Jersey woman says she developed bladder cancer due to routine exposure to hair color chemicals. MORE ABOUT: HAIR DYE LAWSUITHair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)Hairdresser Bladder Cancer Lawsuits Target L’Oréal, Henkel, Wella, Clairol and Other Popular Salon Dye Manufacturers (04/04/2025)Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (03/28/2025)
Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: yesterday) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025)
500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: yesterday) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)